This Apple-like Innovator is Revolutionizing Healthcare

AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.

Click here to learn more about the booming eHealth industry

Peter J. Valenti, III net worth and biography

Peter Valenti, III Biography and Net Worth

Insider of Hologic

Mr. Peter J. Valenti, III, also known as Pete, has been Division President of Breast & Skeletal Health Solutions at Hologic Inc. since May 2014 and served as its Division President of Breast Health. Mr. Valenti is a seasoned industry veteran with nearly 30 years of sales, brand and product management experience, including 20 years focused on healthcare products. His track record includes successful turnarounds of global businesses and establishing and executing on portfolio strategies that helped maximize growth. Mr. Valenti was a Principal and Managing Partner of The New England Consulting Group, Inc. where he served as a consultant to numerous healthcare companies. He served as President of North American Vision Care at Bausch & Lomb Incorporated since September 2011. Mr. Valenti served as Corporate Vice President and Global President of Vision Care at Bausch & Lomb Incorporated since July 1, 2009. Mr. Valenti served as President of North America, Vision Care at Bausch & Lomb Incorporated from January 2009 to July 1, 2009. Mr. Valenti possesses deep leadership experience, as well as considerable eye health and general healthcare expertise. Mr. Valenti served as Vice President and General Manager, Surgical Devices (U.S.), for Covidien, where he led sales and marketing strategy for its billion product portfolio. He spent 12 years with Johnson & Johnson and served in a variety of U.S. and international roles across consumer, pharmaceutical and device businesses. He served as Vice President, Global Strategy and Vice President, U.S. Marketing, both in Vision Care at Johnson & Johnson. Before his career with Johnson & Johnson, he held several brand management roles with Procter & Gamble. He serves as Member of Board of Advisor at Aquatic Safety Concepts, LLC. Mr. Valenti earned an MBA from the Johnson School of Management at Cornell University and a Bachelor of Science in Business Administration from the University of Connecticut.

What is Peter J. Valenti, III's net worth?: The estimated net worth of Peter J. Valenti, III is at least $1.59 million as of May 30th, 2017. Mr. Valenti, III owns 20,994 shares of Hologic stock worth more than $1,587,986 as of April 25th. This net worth evaluation does not reflect any other assets that Mr. Valenti, III may own. Learn More about Peter J. Valenti, III's net worth.
How do I contact Peter J. Valenti, III?: The corporate mailing address for Mr. Valenti, III and other Hologic executives is 250 CAMPUS DRIVE, MARLBOROUGH MA, 01752. Hologic can also be reached via phone at (508) 263-2900 and via email at [email protected]. Learn More on Peter J. Valenti, III's contact information.
Has Peter J. Valenti, III been buying or selling shares of Hologic?: Peter J. Valenti, III has not been actively trading shares of Hologic during the last quarter. Learn More on Peter J. Valenti, III's trading history.
Who are Hologic's active insiders?: Hologic's insider roster includes Benjamin Cohn (Insider), Sally Crawford (Director), Sean Daugherty (Insider), Scott Garrett (Director), John Griffin (General Counsel), Stephen Macmillan (CEO), Essex Mitchell (Insider), Karleen Oberton (CFO), Kevin Thornal (Insider), Peter Valenti, III (Insider), and Jan Verstreken (Insider). Learn More on Hologic's active insiders.
Are insiders buying or selling shares of Hologic?: During the last twelve months, insiders at the medical equipment provider sold shares 7 times. They sold a total of 62,736 shares worth more than $4,696,732.85. The most recent insider tranaction occured on March, 14th when Director Scott T Garrett sold 16,441 shares worth more than $1,241,295.50. Insiders at Hologic own 1.8% of the company. Learn More about insider trades at Hologic.
Information on this page was last updated on 3/14/2024.

Peter J. Valenti, III Insider Trading History at Hologic

Peter J. Valenti, III Buying and Selling Activity at Hologic

Hologic Company Overview

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. The company also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analytics software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, specimen radiology, and connectivity solutions; and breast conserving surgery products. In addition, it provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, the company offers Horizon DXA, a dual energy X-ray system; and Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales, service forces, independent distributors, and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

Today's Range

Now: $75.64

$75.39

$76.97

50 Day Range

MA: $75.95

$73.65

$78.41

2 Week Range

Now: $75.64

$64.02

$87.88

Volume

360,296 shs

Average Volume

1,768,849 shs

Market Capitalization

$17.75 billion

P/E Ratio

35.85

Dividend Yield

N/A

Beta